Rutin Improves Anxiety and Reserpine-Induced Depression in Rats

Molecules. 2022 Oct 27;27(21):7313. doi: 10.3390/molecules27217313.

Abstract

Mental disorders have a poor clinical prognosis and account for approximately 8% of the global burden of disease. Some examples of mental disorders are anxiety and depression. Conventional antidepressants have limited efficacy in patients because their pharmacological effects wear off, and side effects increase with prolonged use. It is claimed that herbal medicine's antioxidant capacity helps regulate people's mood and provide a more substantial pharmacological effect. With this background, the purpose of this study is to investigate the effect of rutin on reserpine-induced anxiety and depression in rats. The animals were divided into groups of six rats each: normal control (water), a depression model, a rutin-treated rat model, and an amitriptyline-treated rat model. According to the results, 14 days of treatment with rutin, once daily, showed a modest antidepressant effect. This effect was mediated by increased serotonin, norepinephrine, and dopamine levels in cortical and hippocampal regions. The antioxidant and vasodilator properties of rutin may contribute to its antidepressant properties. According to this study, rutin has shown antidepressant effects by reducing antioxidant activity and acetylcholinesterase.

Keywords: antidepressant; anxiety; depression; mental disorders; reserpine; rutin.

MeSH terms

  • Acetylcholinesterase
  • Animals
  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use
  • Antioxidants / pharmacology
  • Anxiety / chemically induced
  • Anxiety / drug therapy
  • Depression* / chemically induced
  • Depression* / drug therapy
  • Rats
  • Reserpine*
  • Rutin / pharmacology
  • Serotonin

Substances

  • Reserpine
  • Rutin
  • Serotonin
  • Acetylcholinesterase
  • Antioxidants
  • Antidepressive Agents

Grants and funding

This research received no external funding.